FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:1324-1332 October 2, 2003 Number 14 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Perspective by Ambinder, R. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Infectious mononucleosis–related Epstein–Barr virus (EBV) infection has been associated with an increased risk of Hodgkin's lymphoma in young adults. Whether the association is causal remains unclear.

Methods We compared the incidence rates of Hodgkin's lymphoma in two population-based Danish cohorts of patients who were tested for infectious mononucleosis: 17,045 with serologic evidence of having had acute EBV infection, and 24,614 with no such evidence. We combined the cohort of patients who had serologically verified infectious mononucleosis with a cohort of 21,510 Swedish patients with infectious mononucleosis (combined total, 38,555). Biopsy specimens of Hodgkin's lymphomas occurring during follow-up in this combined cohort were tested serologically for the presence of EBV. Using this information, we modeled the relative risk of EBV-negative and EBV-positive Hodgkin's lymphoma in different periods after the diagnosis of infectious mononucleosis and estimated the median incubation time for mononucleosis-related EBV-positive Hodgkin's lymphoma.

Results Only serologically confirmed infectious mononucleosis was associated with a persistently increased risk of Hodgkin's lymphoma. Sixteen of 29 tumors (55 percent), obtained from patients with infectious mononucleosis, had evidence of EBV. There was no evidence of an increased risk of EBV-negative Hodgkin's lymphoma after infectious mononucleosis. In contrast, the risk of EBV-positive Hodgkin's lymphoma was significantly increased (relative risk, 4.0; 95 percent confidence interval, 3.4 to 4.5). The estimated median incubation time from mononucleosis to EBV-positive Hodgkin's lymphoma was 4.1 years (95 percent confidence interval, 1.8 to 8.3).

Conclusions A causal association between infectious mononucleosis–related EBV infection and the EBV-positive subgroup of Hodgkin's lymphomas is likely in young adults.

Source Information

From the Departments of Epidemiology Research (H.H., K.R., M.F., M. Melbye) and Respiratory Infections, Meningitis, and STDs, Microbiology, and Diagnostics (H.B.K.), Statens Serum Institut; the Danish Institute for Public Health (M. Madsen); the Medical Office of Health, City of Copenhagen (N.R.); and the Department of Cancer Prevention and Documentation, Danish Cancer Society (H.H.S.) — all in Copenhagen, Denmark; the Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute and Hospital, Stockholm, Sweden (J.A.); and the Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark (S.H.-D., J.-S.Z.).

Address reprint requests to Dr. Hjalgrim at the Department of Epidemiology Research, Danish Epidemiology Science Centre, Statens Serum Institut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark, or at hhj{at}ssi.dk.

Full Text of this Article

This article has been cited by other articles:

• Giron-Michel, J., Menard, F., Negrini, S., Devocelle, A., Azzarone, B., Besson, C. (2009). EBV-associated mononucleosis does not induce long-term global deficit in T-cell responsiveness to IL-15. Blood 113: 4541-4547 [Abstract] [Full Text]  
• Chang, E. T., Birmann, B. M., Kasperzyk, J. L., Conti, D. V., Kraft, P., Ambinder, R. F., Zheng, T., Mueller, N. E. (2009). Polymorphic Variation in NFKB1 and Other Aspirin-Related Genes and Risk of Hodgkin Lymphoma. Cancer Epidemiol. Biomarkers Prev. 18: 976-986 [Abstract] [Full Text]  
• Brennan, R. M., Burrows, S. R. (2008). A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis. Blood 112: 2589-2590 [Full Text]  
• Gurer, C., Strowig, T., Brilot, F., Pack, M., Trumpfheller, C., Arrey, F., Park, C. G., Steinman, R. M., Munz, C. (2008). Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 112: 1231-1239 [Abstract] [Full Text]  
• Cozen, W., Gill, P. S., Salam, M. T., Nieters, A., Masood, R., Cockburn, M. G., Gauderman, W. J., Martinez-Maza, O., Nathwani, B. N., Pike, M. C., Van Den Berg, D. J., Hamilton, A. S., Deapen, D. M., Mack, T. M. (2008). Interleukin-2, interleukin-12, and interferon-{gamma} levels and risk of young adult Hodgkin lymphoma. Blood 111: 3377-3382 [Abstract] [Full Text]  
• Hadinoto, V., Shapiro, M., Greenough, T. C., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A. (2008). On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111: 1420-1427 [Abstract] [Full Text]  
• Kapatai, G, Murray, P (2007). Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J. Clin. Pathol. 60: 1342-1349 [Abstract] [Full Text]  
• Smedby, K. E., Hjalgrim, H., Chang, E. T., Rostgaard, K., Glimelius, B., Adami, H.-O., Melbye, M. (2007). Childhood Social Environment and Risk of Non Hodgkin Lymphoma in Adults. Cancer Res. 67: 11074-11082 [Abstract] [Full Text]  
• Oyama, T., Yamamoto, K., Asano, N., Oshiro, A., Suzuki, R., Kagami, Y., Morishima, Y., Takeuchi, K., Izumo, T., Mori, S., Ohshima, K., Suzumiya, J., Nakamura, N., Abe, M., Ichimura, K., Sato, Y., Yoshino, T., Naoe, T., Shimoyama, Y., Kamiya, Y., Kinoshita, T., Nakamura, S. (2007). Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients. Clin. Cancer Res. 13: 5124-5132 [Abstract] [Full Text]  
• Hjalgrim, H., Ekstrom-Smedby, K., Rostgaard, K., Amini, R.-M., Molin, D., Hamilton-Dutoit, S., Schollkopf, C., Chang, E. T., Ralfkiaer, E., Adami, H.-O., Glimelius, B., Melbye, M. (2007). Cigarette Smoking and Risk of Hodgkin Lymphoma: A Population-Based Case-Control Study. Cancer Epidemiol. Biomarkers Prev. 16: 1561-1566 [Abstract] [Full Text]  
• Lunemann, J. D., Kamradt, T., Martin, R., Munz, C. (2007). Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?. J. Virol. 81: 6777-6784 [Full Text]  
• MacArthur, G. J., Wilson, A. D., Birchall, M. A., Morgan, A. J. (2007). Primary CD4+ T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B Cells. J. Virol. 81: 4766-4775 [Abstract] [Full Text]  
• Hjalgrim, H., Ekstrom Smedby, K., Rostgaard, K., Molin, D., Hamilton-Dutoit, S., Chang, E. T., Ralfkiaer, E., Sundstrom, C., Adami, H.-O., Glimelius, B., Melbye, M. (2007). Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma. Cancer Res. 67: 2382-2388 [Abstract] [Full Text]  
• Nielsen, T. R., Rostgaard, K., Nielsen, N. M., Koch-Henriksen, N., Haahr, S., Sorensen, P. S., Hjalgrim, H. (2007). Multiple Sclerosis After Infectious Mononucleosis. Arch Neurol 64: 72-75 [Abstract] [Full Text]  
• Ambinder, R. F. (2007). Epstein-Barr Virus and Hodgkin Lymphoma. ASH Education Book 2007: 204-209 [Abstract] [Full Text]  
• Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J., Khanna, R. (2006). Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood 108: 2280-2289 [Abstract] [Full Text]  
• Landgren, O., Engels, E. A., Pfeiffer, R. M., Gridley, G., Mellemkjaer, L., Olsen, J. H., Kerstann, K. F., Wheeler, W., Hemminki, K., Linet, M. S., Goldin, L. R. (2006). Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.. JNCI J Natl Cancer Inst 98: 1321-1330 [Abstract] [Full Text]  
• Askling, J, Klareskog, L, Blomqvist, P, Fored, M, Feltelius, N (2006). Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis 65: 1184-1187 [Abstract] [Full Text]  
• Lemas, M. V., Ambinder, R. F. (2006). The kiss that scars. Blood 108: 8-8 [Full Text]  
• Sauce, D., Larsen, M., Curnow, S. J., Leese, A. M., Moss, P. A. H., Hislop, A. D., Salmon, M., Rickinson, A. B. (2006). EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood 108: 11-18 [Abstract] [Full Text]  
• Schottenfeld, D., Beebe-Dimmer, J. (2006). Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.. CA Cancer J Clin 56: 69-83 [Abstract] [Full Text]  
• Williams, H., Crawford, D. H. (2006). Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood 107: 862-869 [Abstract] [Full Text]  
• Gandhi, M. K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P. J., Prince, H. M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J. F., Khanna, R. (2006). Plasma Epstein-Barr Virus (EBV) DNA Is a Biomarker for EBV-Positive Hodgkin's Lymphoma. Clin. Cancer Res. 12: 460-464 [Abstract] [Full Text]  
• Paulsen, S. J., Rosenkilde, M. M., Eugen-Olsen, J., Kledal, T. N. (2005). Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor. J. Virol. 79: 536-546 [Abstract] [Full Text]  
• Poppema, S. (2005). Immunobiology and Pathophysiology of Hodgkin Lymphomas. ASH Education Book 2005: 231-238 [Abstract] [Full Text]  
• Cheson, B. D. (2004). What Is New in Lymphoma?. CA Cancer J Clin 54: 260-272 [Abstract] [Full Text]  
• Chang, E. T., Zheng, T., Weir, E. G., Borowitz, M., Mann, R. B., Spiegelman, D., Mueller, N. E. (2004). Childhood Social Environment and Hodgkin's Lymphoma: New Findings from a Population-Based Case-Control Study. Cancer Epidemiol. Biomarkers Prev. 13: 1361-1370 [Abstract] [Full Text]  
• Chang, E. T., Montgomery, S. M., Richiardi, L., Ehlin, A., Ekbom, A., Lambe, M. (2004). Number of Siblings and Risk of Hodgkin's Lymphoma. Cancer Epidemiol. Biomarkers Prev. 13: 1236-1243 [Abstract] [Full Text]  
• Cornelissen, J. J. (2004). Molecular monitoring of EBV-positive lymphoma. Blood 104: 9-9 [Full Text]  
• Brown, J. R., Skarin, A. T. (2004). Clinical Mimics of Lymphoma. The Oncologist 9: 406-416 [Abstract] [Full Text]  
• (2004). Lucina. Arch. Dis. Child. 89: 498-498 [Full Text]  
• Thorley-Lawson, D. A., Gross, A. (2004). Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas. NEJM 350: 1328-1337 [Full Text]  
• Meyer, R. M., Ambinder, R. F., Stroobants, S. (2004). Hodgkin's Lymphoma: Evolving Concepts with Implications for Practice. ASH Education Book 2004: 184-202 [Abstract] [Full Text]  
• (2003). EBV-Mononucleosis and EBV-Hodgkin's Lymphoma: Causal Link Likely. JWatch Infect. Diseases 2003: 8-8 [Full Text]